Cargando…
Development of Plant-Produced Recombinant ACE2-Fc Fusion Protein as a Potential Therapeutic Agent Against SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease (COVID-19) which has recently emerged as a potential threat to global public health. SARS-CoV-2 is the third known human coronavirus that has huge impact on the human population after SARS-CoV...
Autores principales: | Siriwattananon, Konlavat, Manopwisedjaroen, Suwimon, Kanjanasirirat, Phongthon, Budi Purwono, Priyo, Rattanapisit, Kaewta, Shanmugaraj, Balamurugan, Smith, Duncan R., Borwornpinyo, Suparerk, Thitithanyanont, Arunee, Phoolcharoen, Waranyoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874119/ https://www.ncbi.nlm.nih.gov/pubmed/33584747 http://dx.doi.org/10.3389/fpls.2020.604663 |
Ejemplares similares
-
Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana
por: Rattanapisit, Kaewta, et al.
Publicado: (2020) -
Monoclonal Antibodies B38 and H4 Produced in Nicotiana benthamiana Neutralize SARS-CoV-2 in vitro
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2020) -
Immunogenicity Studies of Plant-Produced SARS-CoV-2 Receptor Binding Domain-Based Subunit Vaccine Candidate with Different Adjuvant Formulations
por: Siriwattananon, Konlavat, et al.
Publicado: (2021) -
A recombinant subunit vaccine candidate produced in plants elicits neutralizing antibodies against SARS-CoV-2 variants in macaques
por: Khorattanakulchai, Narach, et al.
Publicado: (2022) -
Immunogenicity and efficacy of recombinant subunit SARS-CoV-2 vaccine candidate in the Syrian hamster model
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2022)